These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs. Gaetani S, Dipasquale P, Romano A, Righetti L, Cassano T, Piomelli D, Cuomo V. Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961 [Abstract] [Full Text] [Related]
5. Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression. Domschke K, Dannlowski U, Ohrmann P, Lawford B, Bauer J, Kugel H, Heindel W, Young R, Morris P, Arolt V, Deckert J, Suslow T, Baune BT. Eur Neuropsychopharmacol; 2008 Oct; 18(10):751-9. PubMed ID: 18579347 [Abstract] [Full Text] [Related]
7. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents. Shearman LP, Stribling DS, Camacho RE, Rosko KM, Wang J, Tong S, Feng Y, Marsh DJ, Yu H, Guan X, Spann SK, Macneil DJ, Fong TM, Metzger JM, Goulet MT, Hagmann WK, Plummer CW, Finke PE, Mills SG, Shah SK, Truong Q, Van der Ploeg LH, Macintyre DE, Strack AM. Eur J Pharmacol; 2008 Jan 28; 579(1-3):215-24. PubMed ID: 18021763 [Abstract] [Full Text] [Related]
8. Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity. Lee SH, Seo HJ, Lee SH, Jung ME, Park JH, Park HJ, Yoo J, Yun H, Na J, Kang SY, Song KS, Kim MA, Chang CH, Kim J, Lee J. J Med Chem; 2008 Nov 27; 51(22):7216-33. PubMed ID: 18954042 [Abstract] [Full Text] [Related]
11. Identification of novel cannabinoid CB1 receptor antagonists by using virtual screening with a pharmacophore model. Wang H, Duffy RA, Boykow GC, Chackalamannil S, Madison VS. J Med Chem; 2008 Apr 24; 51(8):2439-46. PubMed ID: 18363352 [Abstract] [Full Text] [Related]
13. Diarylimidazolyl oxadiazole and thiadiazole derivatives as cannabinoid CB1 receptor antagonists. Kim JY, Seo HJ, Lee SH, Jung ME, Ahn K, Kim J, Lee J. Bioorg Med Chem Lett; 2009 Jan 01; 19(1):142-5. PubMed ID: 19022666 [Abstract] [Full Text] [Related]
14. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands. Song KS, Lee SH, Chun HJ, Kim JY, Jung ME, Ahn K, Kim SU, Kim J, Lee J. Bioorg Med Chem; 2008 Apr 01; 16(7):4035-51. PubMed ID: 18243711 [Abstract] [Full Text] [Related]
15. Substituted pyrimidines as cannabinoid CB1 receptor ligands. Kim MJ, Kim JY, Seo HJ, Lee J, Lee SH, Kim MS, Kang J, Kim J, Lee J. Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4692-7. PubMed ID: 19596576 [Abstract] [Full Text] [Related]
16. Chemical and biological investigation of cyclopropyl containing diaryl-pyrazole-3-carboxamides as novel and potent cannabinoid type 1 receptor antagonists. Szabó G, Varga B, Páyer-Lengyel D, Szemzo A, Erdélyi P, Vukics K, Szikra J, Hegyi E, Vastag M, Kiss B, Laszy J, Gyertyán I, Fischer J. J Med Chem; 2009 Jul 23; 52(14):4329-37. PubMed ID: 19527048 [Abstract] [Full Text] [Related]
17. Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength. Mackie K. Int J Obes (Lond); 2006 Apr 23; 30 Suppl 1():S19-23. PubMed ID: 16570100 [Abstract] [Full Text] [Related]